• 1
    Dano K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Neilsen LS, Skriver L. Plasminogen activators, tissue degradation and cancer. Adv Cancer Res 1985; 44: 139266.
  • 2
    Saksela O, Rifkin DB. Cell-associated plasminogen activation: regulation and physiological functions. Annu Rev Cell Biol 1988; 4: 93126.
  • 3
    Werb Z, Banda MJ, Jones PA. Degradation of connective tissue matrices by macrophages. I. Proteolysis of elastin, glycoproteins and collagen by proteinases isolated from macrophages. J Exp Med 1980; 152: 13401357.
  • 4
    He C, Wilhelm SM, Pentland AP, Marnier BL, Grant GA, Eisen AZ, Goldberg GI. Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. Proc Natl Acad Sci USA 1989; 86: 26322636.
  • 5
    Murphy G, Atkinson S, Ward R, Gavrilovic J, Reynolds J. The role of plasminogen activators in the regulation of connective tissue metalloproteinases. Ann NY Acad Sci 1992; 667: 112.
  • 6
    Woessner JF. Matrix metalloproteinases and their inhibitors in connective tissue remodelling. FASEB J 1991; 5: 21452154.
  • 7
    Ellis V, Pyke C, Eriksen J, Solberg H, Dano K. The urokinase receptor: involvement in cell surface proteolysis and cancer invasion. Ann NY Acad Sci 1992; 667: 1331.
  • 8
    Andreasen PA, Georg B, Lund LR, Riccio A, Stacey SN. Plasminogen activator inhibitors: hormonally regulated serpins. Mol Cell Endocrinol 1990; 68: 119.
  • 9
    Friedman SL, Millward-Sadler GH, Arthur MJP. Liver fibrosis and cirrhosis. In: Millward-SadlerGH, WrightR, ArthurMJP, eds. Wright's liver and biliary disease. 3rd ed. London: Bailliere Tindall, 1992: 821881.
  • 10
    Hendricks HFJ, Blaner WS, Wenneckers HM, Piantedosi R, Brouwer A, De Leeuw AM, Goodman DS, et al. Distributions of retinoids, retinoid-binding proteins and related parameters in different types of liver cells isolated from young and old rats. Eur J Biochem 1988; 171: 237244.
  • 11
    Weiner FR, Blaner WS, Czaja MJ, Shah A, Geerts A. Ito cell expression of a nuclear retinoic acid receptor. Hepatology 1992; 15: 336342.
  • 12
    Burt AD, Robertson JL, Heir J, MacSween RNM. Desmin-containing stellate cells in rat liver: distribution in normal animals and response to experimental acute liver injury. J Pathol 1986; 150: 2935.
  • 13
    Davis BH, Kramer RT, Davidson NO. Retinoic acid modulates rat Ito cell proliferation, collagen, and transforming growth factor β production. J Clin Invest 1990; 86: 20622070.
  • 14
    Friedman SL, Wei S, Blaner WS. Retinol release by activated rat hepatic lipocytes: regulation by Kupffer cell-conditioned medium and PDGF. Am J Physiol 1993; 264: 947952.
  • 15
    Friedman SL, Roll FL, Boyles DM, Bissell DM. Hepatic lipocytes: the principle collagen-producing cells of normal rat liver. Proc Natl Acad Sci USA 1985; 82: 86818685.
  • 16
    Maher JJ, Friedman SL, Roll FJ, Bissell DM. Immunolocalization of laminin in normal rat liver and biosynthesis of laminin by hepatic lipocytes in primary culture. Gastroenterology 1988; 94: 10531062.
  • 17
    Arenson DM, Friedman SL, Bissell DM. Formation of extracellular matrix in normal rat liver: lipocytes as a major source of proteoglycan. Gastroenterology 1988; 95: 441447.
  • 18
    Ramadori G, Rieder H, Knittel T, Dienes HP, Meyer Zum Buschenfelde K. Fat storing cells (FSC) of rat liver synthesize and secrete fibronectin. Comparison with hepatocytes. J Hepatol 1987; 4: 190197.
  • 19
    Iredale JP, Goddard S, Murphy G, Benyon RC, Arthur MJP. Tissue inhibitor of metalloproteinase-1 and interstitial collagenase expression in autoimmune chronic active hepatitis and activated human hepatic lipocytes. Clin Sci 1995; 89: 7581.
  • 20
    Vyas SK, Leyland H, Gentry J, Arthur MJP. Rat hepatic lipocytes synthesize and secrete transin (stromelysin) in early primary culture. Gastroenterology 1995; 109: 889898.
  • 21
    Arthur MJP, Friedman SL, Roll FL, Bissel DM. Lipocytes from normal rat liver release a neutral metalloproteinase that degrades basement membrane (type IV) collagen. J Clin Invest 1989; 84: 10761085.
  • 22
    Iredale JP, Murphy G, Hembry RM, Friedman SL, Arthur MJP. Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1 (TIMP-1): implications for regulation of matrix degradation in liver. J Clin Invest 1992; 90: 282287.
  • 23
    Zeheb R, Gelehtrer TD. Cloning and sequencing of cDNA for the rat plasminogen activator inhibitor-1. Gene 1988; 73: 459468.
  • 24
    Henderson BR, Tansey WP, Phillips SM, Ramshaw IA, Kefford RF. Transcriptional and posttranscriptional activation of urokinase plasminogen activator gene expression in metastatic tumor cells. Cancer Res 1992; 52: 24892496.
  • 25
    Rabbani SA, Rajwans N, Achbarou A, Murthy KK, Goltzman D. Isolation and characterisation of multiple isoforms of the rat urokinase receptor in osteoblasts. FEES Lett 1994; 338: 6974.
  • 26
    Chomcynzski P, Saachi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156159.
  • 27
    Cohen R, Xi X, Crowley C, Lucas B, Levinson A, Shuman M. Effects of urokinase receptor occupancy on plasmin generation and proteolysis of basement membrane by human tumour cells. Blood 1991; 78: 479487.
  • 28
    Labarca C, Paigen K. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 1980; 102: 344352.
  • 29
    Roche PC, Campeau JD, Shaw ST. Comparative electrophoretic analysis of human and porcine plasminogen activators in SDS-polyacrylamide gels containing plasminogen and casein. Biochem Biophys Acta 1983; 745: 8289.
  • 30
    Overall C. A microtechnique for dialysis of small volume solutions with quantitative recoveries. Anal Biochem 1987; 165: 208214.
  • 31
    Coleman PL, Green GDJ. A sensitive, coupled assay for plasminogen activator using a thiol ester substrate for plasmin. Ann NY Acad Sci 1981; 370: 617625.
  • 32
    Sawaya R, Rayford A, Kono S, Ang KK, Feng Y, Stephens LC, Rao JS. Plasminogen activator inhibitor-1 in the pathogenesis of delayed radiation damage in rat spinal cord in vivo. J Neurosurg 1994; 81: 381387.
  • 33
    Sprengers ED, Kluft C. Plasminogen activator inhibitors. Blood 1987; 69: 381387.
  • 34
    Stephens RW, Pollanen J, Tapiovaara H, Leung K-C, Sim P-S, Salonen E-M, Behrendt N. Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants. J Cell Biol 1989; 108: 19871995.
  • 35
    Friedman SL, Yamasaki G, Wong L, Buck J. 14-hydroxy-4, 14-retro-retinol (14-HRR)-a novel metabolite of retinol whose appearance correlates with rat lipocytes activation in vivo and in culture. Hepatology 1992; 16: 143A.
  • 36
    Troen G, Nilsson A, Norum KR, Blomhoff R. Characterisation of liver stellate cell retinyl ester storage. Biochem J 1994; 300: 793798.
  • 37
    Kuiper J, Kamps JAAM, Van Berkel TJC. Identification of the inhibitor of the plasminogen activator as the major protein secreted by endothelial rat liver cells. FEES Lett 1989; 245: 229234.
  • 38
    Reider H, Ramadori G, Meyer Zum Buscehenfelde K-H. The plasmin system of sinusoidal endothelial liver cells in vitro. In: KnookDL, WisseE, eds. Cells of the hepatic sinusoid. Vol. 4. Leiden: Kupffer Cell Foundation, 1993: 4044.
  • 39
    Busso N, Nicodeme E, Chesne C, Guillouzo A, Belin D, Hyafil F. Urokinase and type I plasminogen activator inhibitor production by normal human hepatocytes: modulation by inflammatory agents. Hepatology 1994; 20: 186190.
  • 40
    Heaton JH, Nebes VL, O'Dell LG, Morris SM, Gelehrter TD. Glucocorticoid and cyclic nucleotide regulation of plasminogen activator and plasminogen activator-inhibitor gene expression in primary cultures of rat hepatocytes. Mol Endocrinol 1989; 3: 185192.
  • 41
    Bissell DM, Arenson DM, Maher JJ, Roll FJ. Support of cultured hepatocytes by a laminin-rich gel: evidence for a functionally significant sudendo-thelial matrix in normal rat liver. J Clin Invest 1987; 79: 801812.
  • 42
    Friedman SL, Roll FJ, Boyles J, Arenson DM, Bissell DM. Maintenance of differentiated phenotype of cultured rat hepatic lipocytes by basement membrane matrix. J Biol Chem 1989; 264: 1075610762.
  • 43
    Pinzani M, Gentilini P, Abboud HE. Phenotypical modulation of liver fat-storing cells by retinoids. Influence on unstimulated and growth factor-induced cell proliferation. J Hepatol 1992; 14: 211220.
  • 44
    Sato Y, Tsuboi R, Lyons R, Moses H, Rifkin DB. Characterisation of the activation of latent TGFβ by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system. J Cell Biol 1990; 111: 757763.
  • 45
    Yamaguchi Y, Mann DM, Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 1990; 346: 281284.
  • 46
    Nakatsukasa H, Nagy P, Evarts RP, Hsien CC, Marsden E, Thorgeirsson SS. Cellular distribution of transforming growth factor-β1 and procollagen types I, III and IV transcripts in carbon tetrachloride-induced rat liver fibrosis. J Clin Invest 1990; 85: 18331843.
  • 47
    Castilla A, Prieto J, Fausto N. Transforming growth factors β1 and α in chronic liver disease. Effects of interferon alpha therapy. N Engl J Med 1991; 324: 933940.
  • 48
    Armendariz-Borunda J, Seyer JM, Kang AH, Raghow R. Regulation of TGFbeta gene expression in rat liver intoxicated with carbon tetrachloride. FASEB J 1990; 4: 215221.
  • 49
    Friedman SL, Yamasaki G, Wong L. Modulation of transforming growth factor β receptor of rat lipocytes during the hepatic wound healing response. J Biol Chem 1994; 269: 10551058.
  • 50
    Matsuoka M, Tsukamoto H. Stimulation of hepatic lipocyte collagen production by Kupffer cell-derived transforming growth factor β: implication for a pathogenetic role in alcoholic liver fibrogenesis. Hepatology 1990; 11: 599605.
  • 51
    Meyer DH, Bachem MG, Gressner AM. Modulation of hepatic lipocyte proteoglycan synthesis and proliferation by Kupffer cell-derived transforming growth factors type beta 1 and type alpha. Biochem Biophys Res Commun 1990; 17.
  • 52
    Kojima S, Rifkin DB. Mechanism of retinoid-induced activation of latent transforming growth factor-β in bovine endothelial cells. J Cell Physiol 1993; 155: 323332.
  • 53
    Emonard H, Grimaud JA. Plasminogen activator activity increases during reversal of hepatic fibrosis in murine schistosomiasis. Cell Mol Biol 1990; 36: 233238.
  • 54
    Hart DA, Whidden P, Green F, Henkin J, Woods DE. Partial reversal of established bleomycin-induced pulmonary fibrosis by rh-urokinase in a rat model. Clin Invest Med 1994; 17: 6976.